Evidence map›Paper›PMID 32110352›Full record

ArticleChemical science2019

Development of a hydrolysis-based small-molecule hydrogen selenide (H

Turner D Newton, Michael D Pluth

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Direct hydrogen selenide (HChemical science · 2023
    Article
  10. Review
  11. Biomimetic Construction of Artificial Selenoenzymes.Biomimetics (Basel, Switzerland) · 2023
    Review
  12. Enol-mediated delivery of HChemical science · 2022
    Article
  13. Review
  14. Article
  15. Highly efficient HChemical science · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Turner D NewtonDepartment of Chemistry and Biochemistry , Materials Science Institute , Institute of Molecular Biology , University of Oregon , Eugene , OR 97403 , USA . Email: pluth@uoregon.edu.ORCID 0000-0002-9098-3463
Michael D PluthDepartment of Chemistry and Biochemistry , Materials Science Institute , Institute of Molecular Biology , University of Oregon , Eugene , OR 97403 , USA . Email: pluth@uoregon.edu.ORCID 0000-0003-3604-653X
University of Oregon · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selenium is essential to human physiology and has recently shown potential in the treatment of common pathophysiological conditions ranging from arsenic poisoning to cancer. Although the precise metabolic and chemical pathways of selenium incorporation into biomolecules remain somewhat unclear, many such pathways proceed through hydrogen selenide (H

Identifiers

PMID32110352
PMCPMC7006510
OpenAlexW2980313682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.